BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38441065)

  • 21. Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy.
    Rodriguez AB; Engelhard VH
    Cancer Immunol Res; 2020 Nov; 8(11):1338-1345. PubMed ID: 33139300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures.
    Omotesho QA; Escamilla A; Pérez-Ruiz E; Frecha CA; Rueda-Domínguez A; Barragán I
    Front Immunol; 2024; 15():1348156. PubMed ID: 38333212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.
    Domblides C; Rochefort J; Riffard C; Panouillot M; Lescaille G; Teillaud JL; Mateo V; Dieu-Nosjean MC
    Front Immunol; 2021; 12():698604. PubMed ID: 34276690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
    Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
    Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of tertiary lymphoid structures in cancer.
    You X; Koop K; Weigert A
    Front Immunol; 2023; 14():1286850. PubMed ID: 38111571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
    N J; J T; Sl N; Gt B
    Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas.
    Edmonds NL; Gradecki SE; Katyal P; Lynch KT; Stowman AM; Gru AA; Engelhard VH; Slingluff CL; Mauldin IS
    Oncoimmunology; 2023; 12(1):2164476. PubMed ID: 36632563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
    An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
    Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma.
    Rodriguez AB; Peske JD; Engelhard VH
    Methods Mol Biol; 2018; 1845():241-257. PubMed ID: 30141017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
    Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
    Front Immunol; 2022; 13():868155. PubMed ID: 35664009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
    Rodriguez AB; Peske JD; Woods AN; Leick KM; Mauldin IS; Meneveau MO; Young SJ; Lindsay RS; Melssen MM; Cyranowski S; Parriott G; Conaway MR; Fu YX; Slingluff CL; Engelhard VH
    Cell Rep; 2021 Jul; 36(3):109422. PubMed ID: 34289373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.
    Jia W; Zhang T; Yao Q; Li J; Nie Y; Lei X; Mao Z; Wang Y; Shi W; Song W
    Front Immunol; 2022; 13():870458. PubMed ID: 35844587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
    Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
    Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing the power of oncolytic virotherapy and tertiary lymphoid structures to amplify antitumor immune responses in cancer patients.
    Houel A; Foloppe J; Dieu-Nosjean MC
    Semin Immunol; 2023 Sep; 69():101796. PubMed ID: 37356421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer.
    Zhan Z; Shi-Jin L; Yi-Ran Z; Zhi-Long L; Xiao-Xu Z; Hui D; Pan YL; Pan JH
    Ann Med; 2023 Dec; 55(1):114-126. PubMed ID: 36503344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
    Maoz A; Dennis M; Greenson JK
    Front Immunol; 2019; 10():1884. PubMed ID: 31507584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma.
    Gao Z; Azar J; Zhu H; Williams-Perez S; Kang SW; Marginean C; Rubinstein MP; Makawita S; Lee HS; Camp ER
    Front Immunol; 2024; 15():1324093. PubMed ID: 38361928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer.
    Zhou L; Xu B; Liu Y; Wang Z
    Oncoimmunology; 2021 May; 10(1):1915574. PubMed ID: 34104539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.